Start Date: 5/7/2022 9:30 AM EDT
End Date: 5/7/2022 11:00 AM EDT

Location:

Organization Name: ASNC

Contact:

Join us for the Cardiac Amyloidosis in Latin America: Current Situation and Perspectives webinar to be conducted in Spanish (with slides in English) on Saturday, May 7 at 10:30 am (Brazil, Argentina, Uruguay) / 8:30 am CDT (Mexico) / 9:30 am EDT (Boston, USA).

Leading experts will provide the fundamental concepts allowing healthcare providers (HCPs) to accelerate disease awareness, timely testing, and initiation of targeted transthyretin (ATTR) amyloidosis therapies. The webinar will also provide insights to support and expand development of amyloidosis programs within Latin America.

Participants will receive a lesson book providing important resources to support this effort and a program evaluation to identify ongoing educational needs. 
 

AGENDA and FACULTY Moderators: Fernando Mut, MD, FASNC, Hospital Italiano (Uruguay) Gabriel Grossman, MD, PhD, FASNC, Hospital Moinhos de Vento (Brazil)
10:30 am	Welcome and Introduction	Fernando Mut, MD, FASNC, Hospital Italiano (Uruguay) and Gabriel Grossman, MD, PhD, FASNC, Hospital Moinhos de Vento (Brazil)
10:35 am	AMILO LATAM Group Survey Results	Isabel Carvajal, MD, (México) Instituto Nacional de Cardiologia Ignacio Chavez
10:50 am	Epidemiology of Cardiac Amyloidosis in Latin America: Opportunities to Improve Diagnosis	Juan Erriest, MD (Argentina) Hospital Italiano de La Plata
11:05 am	Role of Nuclear Cardiology in Cardiac Amyloidosis  Diagnosis – What is Possible in Latin America	Amalia Peix, MD, PhD (Cuba) Instituto de cardiología y cirugía cardiovascular de la Habana
11:20 am	Cardiac Amyloidosis Diagnosis Flowchart – Integration of Methods	Marcelo Di Carli, MD, MASNC (USA/Argentina) Brigham and Women's Hospital, Harvard Medical School
11:40 am	Discussion and Questions	Faculty

 

---

Cardiac Amyloidosis in Latin America is being organized by the Latin American Project on Cardiac Amyloidosis (AMILO LATAM) as part of the Reaching Across Latin America educational initiative designed to address ongoing knowledge, competence, and performance among HCPs across twenty countries in Latin America to enhance their skills for diagnosing and managing patients with transthyretin (ATTR) amyloidosis with the goal of improving long-term patient outcomes.